CVE-2023-38956

Published: Aug 3, 2023Modified: Nov 21, 2024

7.5

Vector

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N

Exploitability: 3.9 / Impact: 3.6

Source: NVD

Description

A path traversal vulnerability in ZKTeco BioAccess IVS v3.3.1 allows unauthenticated attackers to read arbitrary files via supplying a crafted payload.

Affected (1)

Products: Zkteco: Bioaccess Ivs

Zkteco

1 product

Bioaccess Ivs

Configuration A

1 vulnerable

Vulnerable Software	Affected Versions
Zkteco Bioaccess Ivs	Version 3.3.1

Related CWEs

CWE-22

Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal')

The product uses external input to construct a pathname that is intended to identify a file or directory that is located underneath a restricted parent directory, but the product does not properly neutralize special elements within the pathname that can cause the pathname to resolve to a location that is outside of the restricted directory.

References (4)

http://zkteco.com

Source: cve@mitre.org

Not Applicable

https://claroty.com/team82/disclosure-dashboard/cve-2023-38956

Source: cve@mitre.org

Third Party Advisory

http://zkteco.com

Source: af854a3a-2127-422b-91ae-364da2661108

Not Applicable

https://claroty.com/team82/disclosure-dashboard/cve-2023-38956

Source: af854a3a-2127-422b-91ae-364da2661108

Third Party Advisory

Timeline

No history available yet.